About SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome
SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome is a rare disease catalogued by Orphanet (ORPHA:157965). It is associated with the SLC39A13 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome trials.
Search ClinicalTrials.gov for "SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome" or filter by Orphanet code ORPHA:157965 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome. Updated daily.